Gráfico del Precio de Acciones NRSN
NRSN Ganando
Neurosense Therapeutics Ltd
$0.8
7.78%
$0.05
Al cierre: Apr 28, 16:00:00 GMT-4
$0.78
-3.57%
$-0.02
Mercado Previo: Apr 29, 06:59:23 GMT-4
Atrás
Neurosense Therapeutics Ltd (NRSN) Ganando
Estadísticas clave
Cierre Anterior
$0.7505
Precio de apertura
$0.8
Rango del día
$0.75 - $0.84
Rango de 52 semanas
$0.63 - $2.6
Volumen
381.5K
Volumen promedio
201.4K
Rendimiento de dividendos
--
EPS (TTM)
-0.62
Cap. de mercado
$27.5M
¿Qué es NRSN?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Características
© 2026 Edgen Powered by